Introduction
============

Ovarian and endometrial cancers are two most common gynecological malignancies [@B1], most often affecting women in their post-menopausal women years. However, recent studies have demonstrated that obesity is associated with increased incidence of endometrial cancer in peri-menopausal women [@B2]. Currently, there are no simple early detection methods available for both cancers, as most often these cancers are already well progressed before any symptoms are detected. In order to improve the survival rate, development of non-invasive detection tools is essential.

Proprotein convertases (PCs) are a family of serine proteases that share a consensus cleavage motif of (K/R-(X)n-(KR)↓(n = 2, 4 or 6, X is any other amino acid) [@B3]. PCs are ubiquitously expressed in normal tissues, but also have a number of important functional roles in various cancers [@B4]-[@B6]. Our previous study has identified furin as the only PC member that is significantly up-regulated in post-menopausal endometrial cancer tissues [@B7]. In addition, the total PC activity in uterine lavage is significantly increased in endometrial cancer patients compared to controls [@B7]. These results suggest that measuring PC activity in uterine lavage may provide a non-invasive detection method for endometrial cancer [@B7].

However, PCs are also reported to be increased in ovarian cancer [@B8], and ovary-derived proteins are found in uterine lavages [@B9]. It is thus uncertain whether increases in lavage PC activity are specific to endometrial cancer or are also associated with ovarian cancer.

In this study, we determined whether the total PC activity in uterine lavage is increased in post-menopausal ovarian cancer patients, and whether assaying total PC activity in uterine lavage can distinguish endometrial and ovarian cancers.

Materials and Methods
=====================

Collection of uterine lavages from ovarian and endometrial cancer patients
--------------------------------------------------------------------------

Sample collection was approved by appropriate Institutional Ethics Committees, with written informed consent from individual patient. Uterine lavage was obtained as previously described [@B10]. In brief, 5 ml of saline was infused transcervically into the uterine cavity with a fine catheter. The fluid was aspirated, centrifuged at 1000 g for 5 min to remove cellular debris, aliquoted and stored at -80^o^C. A total of 89 lavages samples were analyzed for this study, including post-menopausal non-cancer controls (n = 8), ovarian cancer \[benign tumors (n = 21), borderline cancers (n = 4), serous-papillary (n = 21), serous peritoneal (n = 9), other serous subtypes (n = 8), other types of ovarian cancers, including clear cell ovarian tumors and malignant mixed mullerian tumors (MMMT) (n = 7)\], and endometrial cancers (n = 11).

Analysis of PC activity in uterine lavages
------------------------------------------

Total PC activity was determined by the cleavage of a fluorogenic peptide substrate pERTKR-AMC (Bachem, Torrance, CA, USA) [@B10]-[@B12]. A final concentration of 100 μM substrate was incubated with 50 μl of each sample (neat) at 37^o^C in ½ area 96-well plates. The real-time kinetics of substrate hydrolysis (release of AMC from the substrate) was monitored every 5 min for 60 min at excitation/emission of 355/460 nm (Wallac Victor 2 spectrophotometer, PerkinElmer, MA, USA), and the rate of substrate hydrolysis (AMC released per min) was calculated from the linear phase of each real-time kinetic progression curve. To confirm specificity of the assay, representative ovarian cancer lavages were assayed in the absence and presence of a potent PC inhibitor, decanoyl-Arg-Val-Lys-Arg-chloromethylketone (dec-RVKR-CMK, otherwise referred to as CMK) (Bachem, Bubendor, Switzerland) [@B7].

Statistical analysis
--------------------

Data were expressed as mean ± SEM. Statistical analysis used non-parametric, Mann Whitney and Kruskal Wallis test (PRISM, version 6.00, GraphPad software, San Diego, CA). \*\**p*\<0.005 was taken as significant.

Results and Discussion
======================

Total PC activity was detected in all 89 lavage samples examined. The levels were not significantly different between non-cancer controls (n = 8), and ovarian benign tumors (n = 21), borderline cancers (n = 4), serous-papillary (n = 21), serous peritoneal (n = 9), other serous subtypes (n = 8), or other types of ovarian cancer (n = 7) (Figure [1](#F1){ref-type="fig"}A).

All ovarian cancer samples as one group (n = 45) were also not significantly different from controls, benign ovarian tumors (n = 21), or borderline ovarian cancers (n = 4) (Figures [1](#F1){ref-type="fig"}A-B). On the other hand, total PC activity in endometrial cancer lavages (n = 11) was significantly higher than non-cancer controls (n = 8) (Figure [1](#F1){ref-type="fig"}C), consistent with our previous findings [@B7].

To confirm PC specificity in uterine lavage from the ovarian cancer patients, representative ovarian cancer lavages were analyzed with and without a PC inhibitor dec-RVKR-CMK (Figure [2](#F2){ref-type="fig"}). The PC activity was completely abolished following the inhibitor treatment (Figure [2](#F2){ref-type="fig"}), confirming PC specificity.

These results suggest that although total PC activity is detected in uterine lavage of ovarian cancer patients, it is not significantly elevated than controls; this is in contrast to endometrial cancer, demonstrating the specificity of the assay to endometrial cancer [@B7].

In summary, only endometrial cancer but not ovarian patients showed significantly elevated PC activities in their uterine lavages. Therefore, total PC activity in uterine lavage can be used to detect endometrial cancer without being interfered by ovarian cancer.
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![PC activity in uterine lavages from post-menopausal controls, ovarian cancer and endometrial cancer patients. (A) No significant differences were detected in ovarian cancer subtypes \[serous-papillary (n = 21), serous peritoneal (n = 9), other serous subtypes (n = 8), other types of ovarian cancer (n = 7)\] compared to controls (n = 8), benign (n = 21) or borderline cancers (n =4). (B) Comparison of all ovarian cancer subtypes as one group (n = 45) with controls (n = 8), benign tumors (n = 21), or borderline cancers (n = 4). (C) Total PC activity was significantly higher in endometrial cancer (n = 11) compared to controls (n = 8), \*\*p\<0.005.](jcav07p1812g001){#F1}

![Inhibition of PC activity in uterine lavages from ovarian cancer patients by a potent PC inhibitor, decanoyl-Arg-Val-Lys-Arg-chloromethylketone (CMK). Representative progressive curves of PC activity with and without 50 μM CMK in an ovarian cancer lavage is shown.](jcav07p1812g002){#F2}
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